230 related articles for article (PubMed ID: 11884610)
1. Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4.
Leng X; Noble M; Adams PD; Qin J; Harper JW
Mol Cell Biol; 2002 Apr; 22(7):2242-54. PubMed ID: 11884610
[TBL] [Abstract][Full Text] [Related]
2. Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice.
Tong W; Pollard JW
Mol Cell Biol; 1999 Mar; 19(3):2251-64. PubMed ID: 10022912
[TBL] [Abstract][Full Text] [Related]
3. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
5. Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells.
Cheng L; Rossi F; Fang W; Mori T; Cobrinik D
J Biol Chem; 2000 Sep; 275(39):30317-25. PubMed ID: 10906146
[TBL] [Abstract][Full Text] [Related]
6. Cyclin B and cyclin A confer different substrate recognition properties on CDK2.
Brown NR; Lowe ED; Petri E; Skamnaki V; Antrobus R; Johnson LN
Cell Cycle; 2007 Jun; 6(11):1350-9. PubMed ID: 17495531
[TBL] [Abstract][Full Text] [Related]
7. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.
Lowe ED; Tews I; Cheng KY; Brown NR; Gul S; Noble ME; Gamblin SJ; Johnson LN
Biochemistry; 2002 Dec; 41(52):15625-34. PubMed ID: 12501191
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of cyclin-dependent kinase inactivation by progestins.
Musgrove EA; Swarbrick A; Lee CS; Cornish AL; Sutherland RL
Mol Cell Biol; 1998 Apr; 18(4):1812-25. PubMed ID: 9528753
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
Kim DM; Yang K; Yang BS
Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
[TBL] [Abstract][Full Text] [Related]
10. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
[TBL] [Abstract][Full Text] [Related]
11. Defining the substrate specificity of cdk4 kinase-cyclin D1 complex.
Grafstrom RH; Pan W; Hoess RH
Carcinogenesis; 1999 Feb; 20(2):193-8. PubMed ID: 10069453
[TBL] [Abstract][Full Text] [Related]
12. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
Mateyak MK; Obaya AJ; Sedivy JM
Mol Cell Biol; 1999 Jul; 19(7):4672-83. PubMed ID: 10373516
[TBL] [Abstract][Full Text] [Related]
13. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
Pan W; Cox S; Hoess RH; Grafström RH
Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
[TBL] [Abstract][Full Text] [Related]
14. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
Joaquin M; Watson RJ
J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
[TBL] [Abstract][Full Text] [Related]
15. Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage.
Park DS; Morris EJ; Bremner R; Keramaris E; Padmanabhan J; Rosenbaum M; Shelanski ML; Geller HM; Greene LA
J Neurosci; 2000 May; 20(9):3104-14. PubMed ID: 10777774
[TBL] [Abstract][Full Text] [Related]
16. A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase.
Diehl JA; Sherr CJ
Mol Cell Biol; 1997 Dec; 17(12):7362-74. PubMed ID: 9372967
[TBL] [Abstract][Full Text] [Related]
17. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
[TBL] [Abstract][Full Text] [Related]
18. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
Brown NR; Noble ME; Endicott JA; Johnson LN
Nat Cell Biol; 1999 Nov; 1(7):438-43. PubMed ID: 10559988
[TBL] [Abstract][Full Text] [Related]
19. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase.
Suzuki-Takahashi I; Kitagawa M; Saijo M; Higashi H; Ogino H; Matsumoto H; Taya Y; Nishimura S; Okuyama A
Oncogene; 1995 May; 10(9):1691-8. PubMed ID: 7753545
[TBL] [Abstract][Full Text] [Related]
20. Distinct phosphorylation events regulate p130- and p107-mediated repression of E2F-4.
Farkas T; Hansen K; Holm K; Lukas J; Bartek J
J Biol Chem; 2002 Jul; 277(30):26741-52. PubMed ID: 12006580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
